TP53 mutations are significantly enriched in CMP-pattern MDS [14,25], whereas RUNX1, DNMT3A, BCOR, and STAG2 mutations are more prevalent in GMP-pattern MDS [15,16]. Here, RUNX1 is linked to myelodysplastic syndrome.